Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Polymyxin B (500000IU) Injection
Dosage Form : Injection
Packaging Type : Vial
Packaging : 500000 IU
Price : ₹2400/-
Polyflip B Injection contains Polymyxin B (500,000 IU), a potent antibiotic used for treating severe bacterial infections caused by multidrug-resistant Gram-negative bacteria. It is particularly effective against Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, which can cause life-threatening hospital-acquired infections.
Polymyxin B works by disrupting bacterial cell membranes, leading to bacterial cell death. Due to its strong bactericidal properties, it is primarily reserved for critically ill patients when other antibiotics fail.
This injection is commonly used in septicemia, pneumonia, urinary tract infections (UTIs), meningitis, and peritonitis. Since it carries a risk of nephrotoxicity and neurotoxicity, its use is closely monitored in clinical settings.
May cause kidney toxicity, nerve damage, dizziness, muscle weakness, and injection site reactions.
For the treatment of severe Gram-negative bacterial infections, including sepsis, pneumonia, UTIs, and meningitis.
Use only under medical supervision, with dosage monitoring to minimize toxicity risks.
Store at 2°C to 8°C, away from light and moisture. Do not freeze.
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v)
Composition : Tobramycin (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation